Eric J. Rashba, MD, FACC
Professor of Medicine
Director, Electrophysiology
Division of Cardiovascular Medicine

SUNY-Stony Brook Health Sciences Center
T16-080
Stony Brook, NY 11794
Phone: 631-444-3575
Fax: 631-444-1054
E-mail: eric.rashba@stonybrook.edu

EDUCATION AND TRAINING

• BA, Columbia College, New York, NY, 1987
• MD, Yale University College of Medicine
• New Haven, CT, 1992
• Resident in Internal Medicine, Strong Memorial Hospital, University of Rochester, Rochester, NY, 1992-1995
• Fellowship in Cardiology, Tufts-New England Medical Center, Boston, MA 1996-1998
• Fellowship in Cardiac Electrophysiology, Tufts-New England Medical Center, Boston, MA 1998-1999

BOARD CERTIFICATION

• American Board of Internal Medicine, 1995
• American Board of Internal Medicine, Cardiovascular Disease, 1998
• American Board of Internal Medicine, Clinical Cardiac Electrophysiology, 1999

AREAS OF CLINICAL EXPERTISE

• Clinical cardiac electrophysiology
• Radiofrequency ablation procedures for cardiac arrhythmias
• Cardiac pacing and implantable cardioverter-defibrillator (ICD) therapy
• Cardiac resynchronization therapy (CRT)
• Evaluation and management of syncope

CURRENT RESEARCH INTERESTS

• Electrophysiologic effects of late PCI in acute myocardial infarction
• Electrophysiologic effects of Glucose-Insulin-Potassium (GIK) for acute coronary syndromes
• Identification of factors that predict survival benefit from ICD implantation among patients with non-ischemic cardiomyopathy

SPECIAL ACCOMPLISHMENTS/RECENT PUBLICATIONS

• Phi Beta Kappa, Columbia College, 1987
• BA cum laude, Columbia College, 1987
• Passano Foundation Physician Scientist Award, 2001, 2002
• Member, AHA Mid-Atlantic Affiliate Cardiovascular Pathophysiology Peer Review Committee 2002-2006
• NIH K23 Award, “Prognostic significance of T wave variability,” 1/1/02-12/31/06
• NIH R01 Award, “Electrophysiologic effects of late PCI (OAT-EP),” 9/1/02-7/31/06
• NIH U01 Award, “Arrhythmia assessment core lab for IMMEDIATE Trial”, 09/15/2005 - 08/31/2009
• Rashba EJ, Olsovsky MR, Shorofsky SR, Kirk MM, Peters RW, Gold MR. Temporal decline in defibrillation thresholds with an active pectoral lead system. JACC 2001; 38: 1150-5.
• Rashba EJ, Gold MR. Correlation waveform analysis of the atrial signal: the shape of things to come? J Cardiovasc Electrophysiol 2001; 12(2): 150-152.
• Rashba EJ, Bouhouch R, Koshy S, MacMurdy K, Shorofsky SR, Peters RW, Gold MR. A new algorithm for transthoracic cardioversion of atrial fibrillation based on body weight. Am J Cardiol 2001; 88: 1043-45.
• Rashba EJ, Cooklin M, MacMurdy K, Kavesh N, Kirk MM, Sarang S, Peters RW, Shorofsky SR, Gold MR. Effects of selective autonomic blockade on T wave alternans in humans. Circulation 2002 ;105: 837-842.
• Rashba EJ, Bouhouch R, MacMurdy K, Shorofsky SR, Peters RW, Gold MR. Effect of shock polarity on the efficacy of transthoracic atrial defibrillation. Am Heart J 2002; 143: 541-5.
• Gold MR, Shorofsky SR, Bouhouch R, Joy RA, Kirby DS, Osman AF, Rashba EJ. Lack of benefit of an active pectoral pulse generator on atrial defibrillation thresholds. J Cardiovasc Electrophysiol 2002 Apr;13(4):332-5.
• Kirby DS, Gold MR, Rashba EJ, Shorofsky SR. Postentrainment activation sequence: diagnostic of the supraventricular tachycardia mechanism? J Cardiovasc Electrophysiol 2002 Apr;13(4):410-2.
• Rashba EJ, Osman AF, MacMurdy K, Kirk MM, Sarang S, Peters RW, Shorofsky SR, Gold MR. Influence of QRS duration on the prognostic value of T wave alternans. J Cardiovasc Electrophysiol 2002;13(8):770-5.
• Rashba EJ, Osman AF, MacMurdy K, Kirk MM, Sarang S, Peters RW, Shorofsky SR, Gold MR. Exercise is superior to pacing for T wave alternans measurement in subjects with chronic coronary artery disease and left ventricular dysfunction. J Cardiovasc Electrophysiol 2002; 13: 845-850.
• Rashba EJ, Shorofsky SR, Peters RW, Gold MR. Effect of shock polarity on defibrillation thresholds with a hybrid patch-coil lead system. J Intervent Cardiovasc Electrophysiol 2003, 9: 391-396.
• Rashba EJ, Bonner M, Wilson J, Shorofsky SR, Peters RW, Gold MR. Distal right ventricular coil position reduces defibrillation thresholds. J Cardiovasc Electrophysiol 2003; 14: 1036-1040.
• Shorofsky SR, Peters RW, Rashba EJ, Gold MR. Comparison of step-down and binary-search algorithms for determination of defibrillation threshold in humans. PACE 2004; 27: 218-220.
• Gold MR, Breiter D, Leman R, Rashba EJ, Shorofsky SR, Hahn SJ. Safety of a single successful conversion of ventricular fibrillation before the implantation of cardioverter defibrillators. PACE 2003; 26:483-6.
• Rashba EJ, Osman AF, MacMurdy K, Kirk MM, Sarang S, Peters RW, Shorofsky SR, Gold MR. Enhanced detection of arrhythmia vulnerability using T wave alternans, left ventricular ejection fraction, and programmed ventricular stimulation: a prospective study in subjects with chronic ischemic heart disease. J Cardiovasc Electrophysiol 2004; 15: 170-176.
• Rashba EJ, Shorofsky SR, Peters RW, Gold MR. Optimization of atrial defibrillation with a dual-coil, active pectoral lead system. J Cardiovasc Electrophysiol 2004, 15: 790-794.
• Rashba EJ. Assessment of ventricular repolarization abnormalities in congenital long QT syndrome. J Cardiovasc Electrophysiol 2004, 15: 557-559.
• Rashba EJ, Gold MR, Crawford FA, Leman RB, Peters RW, Shorofsky SR. A new protocol for transthoracic cardioversion of atrial fibrillation with a biphasic, truncated exponential shock waveform. Am J Cardiol 2004, 94: 1572-1574.
• Rashba EJ, Shorofsky SR, Brown T, Peters RW, Gold MR. Clinical predictors of atrial defibrillation thresholds with a dual-coil, active pectoral lead system. Heart Rhythm 2005; 2: 49-54.
• Shorofsky SR, Rashba EJ, Havel W, Belk P, DeGroot P, Swerdlow C, Gold MR. Improved defibrillation efficacy in humans with an ascending ramp waveform. Heart Rhythm 2005, 2: 388-394.
• Rashba EJ. Should T wave alternans testing be used to risk stratify candidates for prophylactic ICD implantation? Heart Rhythm 2005, 2: 242-244.
• Rashba EJ, Estes NAM III, Wang P, Schaechter A, Howard A, Zareba W, Couderc J-P, Perkiomaki J, Levine J, Kadish A for the DEFINITE Investigators. Preserved heart rate variability identifies low risk patients with nonischemic dilated cardiomyopathy: Results from the DEFINITE trial. Heart Rhythm 2006; 3: 281-286.
• Rashba EJ, Farasat M, Kirk MM, Shorofsky SR, Peters RW, Gold MR. Effect of an Active Abdominal Pulse Generator on Defibrillation Thresholds with a Dual-Coil, Transvenous ICD Lead System. J Cardiovasc Electrophysiol 2006;17:617-20.
• Rashba EJ, Shorofsky SR, Scheiner A, Peters RW, Ma C, Gold MR. Coronary sinus electrode does not reduce defibrillation thresholds. Heart Rhythm 2006; 3:647-652.
• Stephenson K, Tschabrunn C, Vasu S, Rashba EJ.  When, how and why should sinus rhythm be restored in patients with persistent atrial fibrillation?  Curr Treat Options Cardiovasc Med. 2007 9:372-8.
• Lieberman R, Havel WJ, Rashba E, DeGroot PJ, Stromberg K, Shorofsky SR. Acute defibrillation performance of a novel, non-transvenous shock pathway in adult ICD indicated patients.  Heart Rhythm. 2008 5:28-34.

top